Geron Corp News - GERN

Empower your portfolio: Real-time discussions and actionable trading ideas.

Form 4 - Statement of changes in beneficial ownership of securities

Form 8-K - Current report

Geron Announces FDA Approval of RYTELO™ (imetelstat), a First-in-Class Telomerase Inhibitor, for the Treatment of Adult Patients with Lower-Risk MDS with Transfusion-Dependent Anemia

Approval across ESA ineligible and ESA relapsed/refractory patients with LR-MDS with transfusion-dependent anemia, regardless of ring...

Form 4 - Statement of changes in beneficial ownership of securities

Form 144 - Report of proposed sale of securities

Form 4 - Statement of changes in beneficial ownership of securities

Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Geron Corporation (Nasdaq: GERN), a late-stage clinical biopharmaceutical company, today reported that it has granted non-statutory stock options...

Form 144 - Report of proposed sale of securities

Form 8-K - Current report

Geron Corporation Reports First Quarter 2024 Financial Results and Business Highlights

June 16, 2024 PDUFA date for imetelstat NDA for the treatment of transfusion-dependent anemia in adult patients with lower-risk MDS Geron...

Geron to Announce First Quarter 2024 Financial Results on May 2, 2024

Geron Corporation (Nasdaq: GERN), a late-stage clinical biopharmaceutical company, today announced that it will release its first quarter 2024...

Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Geron Corporation (Nasdaq: GERN), a late-stage clinical biopharmaceutical company, today reported that it has granted non-statutory stock options...

Geron to Participate at Upcoming Investor Conferences in April

Geron Corporation (Nasdaq: GERN), a late-stage clinical biopharmaceutical company, today announced that John A. Scarlett, M.D., Geron’s Chairman...

Spike5 2 days ago

Where is that bigmouth big bambino . He has been awfully quiet . Probably because like I said you have fda approval and it cannot get above 5 dollars . Once again I am not shorting this stock I have not and never will short any stock but also once again I will not say a good word about how terrible this company is being ran . And also because I already lost a lot of money on this stock .

👍️0

Spike5 4 days ago

If this gets under 4 it’s over .

👍️0

Spike5 1 week ago

Wow …. This will be down to nothing soon … this company will never be worth shit because the people running it do not want it to be . I lost money back when this company did what it is doing now . No im not shorting this stock but I’m also not going to say anything good about this company . But you have delusional idiots on this board who think this is going up to a hundred . I don’t want to see what happened to me happen to others . I’m tired of management being the only ones making money

Ok that’s funny I’ll stop my nonsense .they are going to get a buy out for billions with sales that are not even one million. The truth hurts !

👍️0

learningcurve2020 2 weeks ago

Stop your nonsense. They finally have revenues! Now it's only about growing pains, hopefully.

>>08:59 AM EDT, 08/08/2024 (MT Newswires) -- Geron (GERN) reported a Q2 net loss Thursday of $0.10 per diluted share, widening from a loss of $0.09 a year earlier.

Analysts polled by Capital IQ expected a per-share loss of $0.10.

Revenue for the quarter ended June 30 was $882,000, up fro $29,000 a year earlier.

Analysts surveyed by Capital IQ expected $290,000.

As of June 30, the company said it had $430.4 million in cash, cash equivalents and marketable securities, which, together with projected revenue from US sales of Rytelo, will be enough to fund its expected operating requirements into Q2 of 2026.

👍️0

Spike5 2 weeks ago

Well sorry to people who thought this was going somewhere… unfortunately the shorts are going to win this one .

👍️0

attilathehunt 2 weeks ago

Someone placed 19k on this weeks' 5 call options....They expect at least 5.10 in two days.

👍️0

Spike5 3 weeks ago

I have never seen a stock that cannot hold gains … it’s sad

👍️0

attilathehunt 3 weeks ago

Lots of call options trading today!

Someone truly likes the Jan 7 options!!

👍️0

Spike5 3 weeks ago

Oh boy this is going to get smashed today

👍️0

learningcurve2020 4 weeks ago

"Geron Announces Updated NCCN Guidelines® Recommending RYTELO™ (imetelstat) for the Treatment of Symptomatic Anemia in Patients with Lower-Risk MDS"

👍️0

seward 4 weeks ago

I wish I had bought every dip this year. But I loaded up on CDs instead.

Still holding 3 positions.

👍️0

learningcurve2020 1 month ago

LOL...A guy? You mean the Chief of Commercialization. Of course that's why it's down.

>>This collaspe is not because of a guy leaving the company

👍️0

Spike5 1 month ago

This collaspe is not because of a guy leaving the company it’s because they have nothing new to offer and fda approval was an abject failure.and investors are scared

👍️0

learningcurve2020 1 month ago

You just told people here he holds his shares when there's a Form 4 showing he sold and still holds some shares. I suspect you simply don't know how to read filings.

👍️0

big bambino 1 month ago

Curve, I'm not giving out bad information. No one knows how many shares are still held by individuals. I'm also not disputing the sales of executives. That being said, no one knows why people sell shares. No one is expected to hold on forever, that is why we invest.

👍️0

learningcurve2020 1 month ago

BigBambino giving out bad information. In fairness a number of execs sold around the same time on FDA approval. What's he have left about 170k shares?

👍️0

big bambino 1 month ago

All I'm saying is, when I pull out of stock (whether with a loss or gain) I move on to my other or future holdings. To hang around a board and post regularly for years only to post negative views is basically concerning. To sell shares at a loss, deserves a negative response. But to hang around for years, with no skin in the game tends to send up red flags as to why. I myself being a long, will only view further post and restrain from engaging any further. Best of luck to all longs, which I believe will be rewarded. Seeing as we've already regained 5% back from loss's, let's wait and see 😀

👍️ 1

learningcurve2020 1 month ago

That's what I suggested earlier. Almost seems too obvious so I'm skeptical...But hopeful.

👍️0

Stumblebum 1 month ago

On June 10 of this year kapur sold 421,875 shares @$4.64…. Go to geron insider trading all activity is posted there ….not a good sign imo

👍️0

big bambino 1 month ago

Maybe this was a decision with a possible takeover. Go and look for an alternate position somewhere else, since they wouldn't need 2 in that position. I think how the stocks end's up after Friday, may tell us a little more.

👍️0

learningcurve2020 1 month ago

Not me. Geron has way too loooong a history of torturing shareholders. Waiting to see some actual market penetration.

👍️0

learningcurve2020 1 month ago

Hard to imagine why a Chief of commercialization would walk away right as they begin to commercialize?? Talk about spooking investors. Well, atleast they seem to have a capable back up on the BOD.

👍️0

big bambino 1 month ago

Your right. I myself think someone (like myself) is looking to pick up some really cheap shares. Only time will tell, but is surely interesting 😀

👍️0

learningcurve2020 1 month ago

It almost seems like a set up to "shake the tree". But this is Geron after all, so who really knows.

👍️0

big bambino 1 month ago

let's not forget, he may have put in a resignation, but still holds his shares. If you can show me he sold all his shares, then maybe, maybe I would be concerned.

👍️0

big bambino 1 month ago

This is a bonus buying opportunity, just purchased another 1500 @ $4.26. So everyone knows how much I'm invested here. There is no way an FDA approved, life changing drug should be going down. To go down 10% on only 5m shares is a direct indication of who is controlling this. Wishing the longs all the future best that we shall see. If you are looking for a quick buck, than day trade. If your looking for a big payout, which I am, then we should hold.

👍️ 1

learningcurve2020 1 month ago

Grrrrrron. Always such an uphill battle. Well, maybe he knows a buyout is coming??

"Geron Corporation Announces Chief Commercial Officer to Depart at End of August 2024"

👍️0

Spike5 1 month ago

OMG! This is going to be down again .

👍️0

big bambino 1 month ago

1000 @ $4.65

👍️0

big bambino 1 month ago

Forgot to mention, will use that found money to purchase more today 😁

👍️0

big bambino 1 month ago

I hope my fellow long share holders filled out there form for the class action. I received a check for $7300 for my shares of period in 2018. That alone has made up a good chunk of my initial shares (which is paid for 10x's over). To have this at almost $5, still without any direction is phenomenal. if following trading sequence will notice, downward pressure is with share purchase of less then 100 shares. When direction is announced, this should go skyward. ALL JMHO and wish the best for all long's, GOD bless.

👍️0

Spike5 1 month ago

The geron giveback is underway ….

👍️0

barcode27 1 month ago

GERN is 30x the size of MAIA. Wouldn't be a merger, would be an acquisition.

👍️0

attilathehunt 1 month ago

Who is MAIA?

3 trades totaled 5.2m shares....something is up....Perhaps news on Monday or Tuesday

👍️0

Stumblebum 1 month ago

Gern and Maia merger?

👍️0

Spike5 2 months ago

The shorts will never let this stock ever go up … it’s sad when you get fda approval and that is not even close to being enough . A buy out will be the only thing that makes this stock go

👍️0

Spike5 2 months ago

It’s a disgrace what management has done to this company it could have been a great stock ..

👍️0

Spike5 2 months ago

I’m pissed and I sold a long time ago for a loss but in retrospect it looks like this has no bottom and not another ounce of any news to lift it any time soon if at all . Absolutely disastrous results after approval .

👍️0

big bambino 2 months ago

Booyaa

👍️0

Stumblebum 2 months ago

Agree let’s get that buyout moving 💰💵

👍️0

big bambino 2 months ago

Looks like the 4k I purchased (from the guidance of a nameless lady) along with my other 23k @ $1.80 appx, is starting to really look good. now to just sit back, watching Missy grow 🤣🤣

👍️0

Spike5 2 months ago

Wow! This is just sad no other way to see it

👍️0

Stumblebum 2 months ago

My thoughts remain if Gern gets bought out and hopefully they will….I feel INCY is the ideal candidate…..they are constantly buying other companies….and I won’t be surprised if was a stock swat instead of a cash offer…..JMO

👍️0

attilathehunt 2 months ago

So what is the future worth of GERN?

My guess between $11 -$13 share ($6.5B -$8B)

Market size for MDS:

Global MDS Treatment Market: Estimates suggest the global MDS treatment market was valued at around:

$3.2 - $3.5 billion in 2022 [Sources: Coherent Market Insights, Credence Research]
It's expected to grow at a Compound Annual Growth Rate (CAGR) of:
5.56% - 9.5% by 2032 [Sources: Coherent Market Insights, Credence Research, Market.us]
Focus on MDS Drugs: If the focus is solely on MDS drugs, the market size was estimated at:

$2.39 billion in 2022 [Market.us]
Projected to reach $5.79 billion by 2032 with a CAGR of 9.5% [Market.us]
Factors Driving Market Growth:

Rising prevalence of MDS due to an aging population
Growing awareness and improved diagnosis of MDS
Introduction of novel drugs for treatment
Increasing research on bone marrow transplantation

👍️0

attilathehunt 2 months ago

Get the deal done over the weekends perhaps??

Or..I'm thinking the PR hit the news wire (just before close) for Monday morning 7 am release....They are a West Coast company (Foster City, Cal) so probably someone didn't want to go into work before 4 am to set up the PR...`This would explain the sudden jump starting at 3:40.

It was also triple witching however I estimated about 3m shares would be exercised....Still a long ways from the 14m at the close.

👍️0

learningcurve2020 2 months ago

Saw that. Nice little run. Get the deal done over the weekends perhaps??

👍️0

attilathehunt 2 months ago

yep...something is happening.

Appx 3.5m shares traded in the last 20 minutes and then BANG 14M. block at the close.

No rebalancing on funds that I am aware so this must mean something come Monday....

How to see BO at $10+...

👍️0

Spike5 2 months ago

Sorry I mean you are correct … I have turned spell check off on my phone more times than I can count

👍️0

Market Data

News

Trading Tools

Markets

Discover

Hot Features

Follow Feed

Options Flow

Monitor

Geron Corp (GERN)

Empower your portfolio: Real-time discussions and actionable trading ideas.

GERN News

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 8-K - Current report

Geron Announces FDA Approval of RYTELO™ (imetelstat), a First-in-Class Telomerase Inhibitor, for the Treatment of Adult Patients with Lower-Risk MDS with Transfusion-Dependent Anemia

Form 4 - Statement of changes in beneficial ownership of securities

Form 144 - Report of proposed sale of securities

Form 4 - Statement of changes in beneficial ownership of securities

Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Form 144 - Report of proposed sale of securities

Form 8-K - Current report

Geron Corporation Reports First Quarter 2024 Financial Results and Business Highlights

Geron to Announce First Quarter 2024 Financial Results on May 2, 2024

Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Geron to Participate at Upcoming Investor Conferences in April

GERN Discussion

Your Recent History

Company

Business

Popular

Get The App

Trending Now

Toplists

Market Data

News

Trading Tools

Markets

Discover

Hot Features

Follow Feed

Options Flow

Monitor

Geron Corp (GERN) News

Geron Corp (GERN)

Empower your portfolio: Real-time discussions and actionable trading ideas.

GERN News

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 8-K - Current report

Geron Announces FDA Approval of RYTELO™ (imetelstat), a First-in-Class Telomerase Inhibitor, for the Treatment of Adult Patients with Lower-Risk MDS with Transfusion-Dependent Anemia

Form 4 - Statement of changes in beneficial ownership of securities

Form 144 - Report of proposed sale of securities

Form 4 - Statement of changes in beneficial ownership of securities

Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Form 144 - Report of proposed sale of securities

Form 8-K - Current report

Geron Corporation Reports First Quarter 2024 Financial Results and Business Highlights

Geron to Announce First Quarter 2024 Financial Results on May 2, 2024

Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Geron to Participate at Upcoming Investor Conferences in April

GERN Discussion

Your Recent History

Company

Business

Popular

Get The App